[go: up one dir, main page]

RU2001116117A - NEW PIPERAZINE AND PIPERIDINE COMPOUNDS - Google Patents

NEW PIPERAZINE AND PIPERIDINE COMPOUNDS

Info

Publication number
RU2001116117A
RU2001116117A RU2001116117/04A RU2001116117A RU2001116117A RU 2001116117 A RU2001116117 A RU 2001116117A RU 2001116117/04 A RU2001116117/04 A RU 2001116117/04A RU 2001116117 A RU2001116117 A RU 2001116117A RU 2001116117 A RU2001116117 A RU 2001116117A
Authority
RU
Russia
Prior art keywords
formula
compound
compound according
compounds
methyl
Prior art date
Application number
RU2001116117/04A
Other languages
Russian (ru)
Other versions
RU2225406C2 (en
Inventor
Рулоф В. Фенстра
М. ВАН ДЕР ХЕЙДЕН Йоханнес А.
Йоханнес МОС
Стефен К. ЛОНГ
Гербен М. ВИССЕР
Корнелис Г. Крусе
СХАРРЕНБУРГ Густаф Й. М. ВАН
Геррит П. ТОРОП
Original Assignee
Дюфар Интернэшнл Рисерч Бв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дюфар Интернэшнл Рисерч Бв filed Critical Дюфар Интернэшнл Рисерч Бв
Publication of RU2001116117A publication Critical patent/RU2001116117A/en
Application granted granted Critical
Publication of RU2225406C2 publication Critical patent/RU2225406C2/en

Links

Claims (11)

1. Соединения формулы (I)1. The compounds of formula (I)
Figure 00000001
Figure 00000001
 где S1 представляет водород, галоген, алкил(1-3С), CN, CF3, OCF3, SCF3, алкокси (1-3С), амино или моно- или диалкил(1-3С)замещенный амино, или гидрокси;where S 1 represents hydrogen, halogen, alkyl (1-3C), CN, CF 3 , OCF 3 , SCF 3 , alkoxy (1-3C), amino or mono- or dialkyl (1-3C) substituted amino, or hydroxy; Z представляет =С или -N;Z represents = C or —N; R1 и R2 независимо представляют Н или алкил(1-3С), или R1 и R2 вместе могут образовывать мостик из 2 или 3 атомов углерода,R 1 and R 2 independently represent H or alkyl (1-3C), or R 1 and R 2 together can form a bridge of 2 or 3 carbon atoms, R4 представляет водород или алкил(1-3С),R 4 represents hydrogen or alkyl (1-3C), Q представляет метил, этил, этил, замещенный одним или несколькими атомами фтора, или циклопропилметил, необязательно замещенный одним или несколькими атомами фтора,Q is methyl, ethyl, ethyl substituted with one or more fluorine atoms, or cyclopropylmethyl optionally substituted with one or more fluorine atoms, и их соли и пролекарства.and their salts and prodrugs. 2. Соединения по п.1, где S1, R1, R2 и R4 представляют водород, Q представляет метил или этил и Z имеет значение, определенное в п.1.2. The compounds of claim 1, wherein S 1 , R 1 , R 2, and R 4 are hydrogen, Q is methyl or ethyl, and Z is as defined in claim 1. 3. Соединения по п.2, где Z представляет -N.3. The compound of claim 2, wherein Z is —N. 4. Соединение по п.3, где Q представляет метил.4. The compound according to claim 3, where Q is methyl. 5. Способ получения соединении по п.1 реакцией взаимодействия соединения формулы (I), где Q представляет водород, с соединением формулы Q-Hal, где Q представляет метил или (необязательно фторированный)этил, (необязательно фторированный) циклопропилметил и Hal представляет галоген.5. A method for producing a compound according to claim 1 by reacting a compound of formula (I), where Q is hydrogen, with a compound of formula Q-Hal, where Q is methyl or (optionally fluorinated) ethyl, (optionally fluorinated) cyclopropylmethyl and Hal is halogen. 6. Способ получения соединений по п.1, где Z представляет -N, взаимодействием соединения формулы (II)6. The method of producing compounds according to claim 1, where Z is —N, by reacting a compound of formula (II)
Figure 00000002
Figure 00000002
 с соединением формулы (III)with a compound of formula (III)
Figure 00000003
Figure 00000003
 при этом в указанных формулах символы имеют значения, определенные в п.1.while in these formulas, the symbols have the meanings defined in paragraph 1. 7. Способ получения соединений формулы (I), где Z представляет =С, взаимодействием соединения формулы (IV)7. A method of obtaining compounds of formula (I), where Z represents = C, by the interaction of compounds of formula (IV)
Figure 00000004
Figure 00000004
 с производным пиперидона, которое необязательно является R1 и/или R2 замещенным и имеет группу Q, с последующим дегидрированием и снятием защиты.with a piperidone derivative, which is optionally R 1 and / or R 2 substituted and has a Q group, followed by dehydrogenation and deprotection. 8. Фармацевтическая композиция, которая в качестве активного компонента содержит, по меньшей мере, одно соединение по п.1.8. The pharmaceutical composition, which as an active component contains at least one compound according to claim 1. 9. Способ получения фармацевтической композиции, отличающийся тем, что соединение по п.1 приводят в форму, подходящую для введения.9. A method of obtaining a pharmaceutical composition, characterized in that the compound according to claim 1 is brought into a form suitable for administration. 10. Способ лечения расстройств ЦНС, отличающийся тем, что используют соединение по п.1.10. A method of treating CNS disorders, characterized in that the compound according to claim 1 is used. 11. Способ лечения беспокойства и/или депрессии, отличающийся тем, что используют соединение по п.1.11. A method of treating anxiety and / or depression, characterized in that the compound according to claim 1 is used.
RU2001116117/04A 1998-11-13 1999-11-10 Alkyl-piperazinyl benzoxazolone and alkyl-piperidinyl benzoxazolone derivatives, method for their preparing and method for treatment RU2225406C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203871.3 1998-11-13
EP98203871 1998-11-13

Publications (2)

Publication Number Publication Date
RU2001116117A true RU2001116117A (en) 2003-05-27
RU2225406C2 RU2225406C2 (en) 2004-03-10

Family

ID=8234340

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001116117/04A RU2225406C2 (en) 1998-11-13 1999-11-10 Alkyl-piperazinyl benzoxazolone and alkyl-piperidinyl benzoxazolone derivatives, method for their preparing and method for treatment

Country Status (27)

Country Link
US (1) US6780864B1 (en)
EP (1) EP1131308B1 (en)
JP (1) JP3638874B2 (en)
KR (1) KR100619465B1 (en)
CN (1) CN1225462C (en)
AR (1) AR021256A1 (en)
AT (1) ATE267183T1 (en)
AU (1) AU756470B2 (en)
BR (1) BR9915293B1 (en)
CA (1) CA2350137C (en)
CZ (1) CZ299774B6 (en)
DE (1) DE69917478T2 (en)
DK (1) DK1131308T3 (en)
DZ (1) DZ2934A1 (en)
ES (1) ES2217833T3 (en)
HU (1) HUP0104922A3 (en)
IL (2) IL143028A0 (en)
MX (1) MXPA01004854A (en)
NO (1) NO318888B1 (en)
NZ (1) NZ511584A (en)
PL (1) PL193685B1 (en)
RU (1) RU2225406C2 (en)
SI (1) SI1131308T1 (en)
SK (1) SK285648B6 (en)
TW (1) TWI252230B (en)
UA (1) UA71590C2 (en)
WO (1) WO2000029397A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
CA2405758A1 (en) * 2000-05-12 2001-11-15 Solvay Pharmaceuticals B.V. Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
ES2211809T3 (en) * 2000-05-12 2004-07-16 Solvay Pharmaceuticals B.V. PIPERAZINE AND PIPERIDINE COMPOSITE.
JP2004513915A (en) * 2000-11-14 2004-05-13 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング Novel use of multiple selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists
AR034206A1 (en) * 2001-02-16 2004-02-04 Solvay Pharm Bv A PROCEDURE FOR THE PREPARATION OF MESILATES OF PIPERAZINE DERIVATIVES AND SUCH MESILATES
US6800648B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-1,6,9-trioxa-3-AZA-cyclopenta[a]naphthalen-2-one
US6743796B2 (en) 2001-05-07 2004-06-01 Wyeth Piperazinyl-isatins
DE60231507D1 (en) 2001-07-20 2010-07-01 Psychogenics Inc TREATMENT OF HYPERACTIVITY DISORDERS AND ATTENTION DEFICITS
ES2280602T3 (en) 2001-07-26 2007-09-16 Merck Patent Gmbh USE OF 2- (5- (4-FLUOROPHENYL) -3-PIRIDYLMETHYLAMINOME) -CROMANO AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS.
EP1336406A1 (en) * 2002-02-14 2003-08-20 Solvay Pharmaceuticals B.V. Partial dopamine-D2 receptor agonist plus serotonin and/or noradrenaline inhibitory activity
WO2004000837A1 (en) * 2002-06-25 2003-12-31 Sumitomo Pharmaceuticals Co., Ltd. Novel benzoxazolinone derivative
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
EP1595542A1 (en) * 2004-03-26 2005-11-16 Solvay Pharmaceuticals B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
US7596407B2 (en) 2004-03-26 2009-09-29 Solvay Pharmaceuticals, B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
DE602005016244D1 (en) * 2004-05-27 2009-10-08 Ucb Pharma Sa BENZOXAZOLE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR APPLICATIONS
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7964604B2 (en) 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US7423040B2 (en) 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
AR058022A1 (en) * 2005-08-22 2008-01-23 Solvay Pharm Bv DERIVATIVES OF BENZOOXAZOLES, PHARMACEUTICAL COMPOSITIONS AND ITS USE FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS.
US7750013B2 (en) 2005-08-22 2010-07-06 Solvay Pharmaceuticals, B.V. N-oxides as prodrugs of piperazine and piperidine derivatives
ES2318783T3 (en) * 2005-08-22 2009-05-01 Solvay Pharmaceuticals B.V. N-OXIDES AS PROPHARMACES OF PIPERAZINE AND PIPERADINE DERIVATIVES.
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
UY32934A (en) * 2009-10-12 2011-05-31 Abbott Healthcare Products Bv PARDOPRUNOX MONOHIDRATE
CA3034895A1 (en) 2016-08-26 2018-03-01 Exciva Ug (Haftungsbeschrankt) Compositions and methods thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2567884B1 (en) * 1984-07-19 1987-03-06 Roussel Uclaf NEW INDOLE DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
EP0189612B1 (en) * 1984-12-21 1992-11-04 Duphar International Research B.V New pharmaceutical compositions having a psychotropic activity
ATE44528T1 (en) * 1984-12-21 1989-07-15 Duphar Int Res MEDICATIONS WITH ANTIPSYCHOTIC EFFECTS.
DK148392D0 (en) 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocyclic Compounds
IL114026A (en) 1994-06-08 1999-06-20 Lundbeck & Co As H 4-aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzo thiophenemethyl) piperidines tetrahydropyridines or piperazines and pharmaceutical compositions containing them
EP0773942A1 (en) * 1994-07-26 1997-05-21 Pfizer Inc. 4-indole derivatives as serotonin agonists and antagonists
PL189256B1 (en) 1996-03-29 2005-07-29 Duphar Int Res Chemical compounds of piperazine and piperidine
EP0900792B1 (en) * 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists

Similar Documents

Publication Publication Date Title
RU2001116117A (en) NEW PIPERAZINE AND PIPERIDINE COMPOUNDS
SU1470183A3 (en) Method of producting amide derivatives of quinoline of their acid-addition salts
US5859246A (en) 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
ATE225348T1 (en) SUBSTITUTED AZAINDOLYLIDE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
KR950008510A (en) Piperidine and Piperazine
CA2324418A1 (en) Novel opiate compounds, methods of making and methods of use
RU98102128A (en) DERIVATIVES OF BENZO [G] QUINOLINE
RU2002107318A (en) NEW Phenylpiperazines
RU2002133458A (en) Compounds of piperazine and piperidine
MXPA01004854A (en) New piperazine and piperidine compounds.
KR920701177A (en) 3-aryloxazolidinone derivatives, methods for their preparation and therapeutic uses thereof
RU2004126700A (en) Synthesis of Ecteinascidins Encountered in Nature and Related Compounds
KR860008973A (en) 2-pyrrolidone derivatives
EA200200611A1 (en) NEW TETRAHYDROPYRIDINES, METHOD FOR THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
HUT50327A (en) Process for producing 2-square brackets open /piperidin-4-yl/-methyl square brackets closed-1,2,3,4-tetrahydro-isoquinoline derivatives and pharmaceutical compositions comprising same
TR200100660T2 (en) Piperidine derivatives.
KR960702456A (en) NP-Halobenzoylmethyl Derivatives of 4- (P-Fluorophenyl) -3-[(3,4- (methylenedioxy) phenoxy) methyl] piperidine ) -3-[[3,4- (METHYLENEDIOXY) PHENOXY] METHYL] PIPERIDINE)
ATE104294T1 (en) ANTI-SYCHOTIC COMPOUNDS.
ES2111086T3 (en) AMPHOTERIC TRICYCLIC COMPOUNDS AS ANTIHISTAMINE AND ANTIALLERGIC AGENTS.
KR920012100A (en) Bisphosphonic acid derivatives, their preparation and uses
YU13003A (en) Prodrugs to nmda receptor ligands
ATE304535T1 (en) METHOD FOR PRODUCING 3(2H)PYRIDAZINONE-4-SUBSTITUTED AMINO-5-CHLORO DERIVATIVES
KR840008347A (en) Process for preparing substituted piperazin-1-yl-acetic acid amide
ES8105981A1 (en) 4-(Naphthalenyloxy)piperidine Derivatives
KR880006164A (en) 1-aryloxy-3-amino-2-propanol, methods of making and uses thereof